Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions

Boehringer Ingelheim

Status: Completed

Conditions: Arthritis, Rheumatoid

Treatments: Drug: Meloxicam

Study type: Observational

Funder types: Industry

Identifiers

NCT02184052

107.267

Details and patient eligibility

About

Study to determine the safety and efficacy of Mobic® ampoules in the initiation of treatment of painful exacerbations of osteoarthritis, rheumatoid arthritis and other similar painful inflammatory conditions.

Enrollment: 121 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Painful acute exacerbations of inflammatory rheumatism (rheumatoid arthritis and ankylosing spondylitis), painful acute exacerbations of osteoarthritis and other similar conditions requiring acute treatment with an anti-inflammatory drug

Exclusion criteria

• none

Trial design

121 participants in 1 patient group

Meloxicam

Treatment:

Drug: Meloxicam